AbbVie Inc. vs Merck & Company, Inc. — Stock Comparison
Q·Score Breakdown
6.1
Hold
Overall
7.3
Buy
Quality
Health
Growth
Valuation
Sentiment
ABBV
72% of 32 covering analysts rate it Buy or Strong Buy.
⚠ earnings contracting 46% year-over-year.
MRK
High-quality business with 37% return on equity and 28% profit margins.
⚠ earnings contracting 19% year-over-year.
Analyst Consensus
BUY
Target $249.27 (+16.7%)
30 analysts
BUY
Target $129.74 (+16.9%)
27 analysts
Fundamentals
ABBV
MRK
104.7×
Trailing P/E
15.2×
13.2×
Forward P/E
11.4×
5.8%
Profit Margin
28.1%
72.0%
Gross Margin
77.2%
—
ROE
36.9%
12.4%
Revenue Growth
5.0%
-45.8%
Earnings Growth
-19.3%
—
Beta
0.28
—
Price / Book
—
$377.8B
Market Cap
$274.2B
$177 – $245
52-Week Range
$73 – $125
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.